The March of Deep Learning in Medicine Continues - DZone Big Data

I've looked before at the growing role AI is playing in the development of new medicines, whether it's understanding which compounds to test, or even in the creation of virtual models to test drugs in. At the forefront of this trend is Insilico Medicine, who you may remember I wrote about recently after they'd developed a system that can guess your age accurately just by looking at you. They have certainly been busy and recently published a paper looking at the role of deep learning in predicting the impact drugs might have on the body. The study saw a neural network trained up to predict the therapeutic use of a huge array of drugs. The team measured the differential signaling pathway activation score for a wide range of different pathways to reduce the dimensionality of the data, whilst ensuring that it remained scientifically relevant.